Discussion Questions 1 & 2
DQ 1: Risk Management
Case 9-1 discusses Young Again Pharmaceuticals. The three options that this firm has to manage risk are risk retention, risk transfer, or a mixed approach. In 200 - 250 words, discuss your recommendations on how this company should evaluate and implement these techniques to manage risks.
DQ 2: Mitigated Risk
Given your answer to Discussion Forum 1, discuss in 200 - 250 words what you believe Young Again Pharmaceuticals should focus on once the risks are mitigated.